HCPCS J0717
Certolizumab pegol injection 1mg
HCPCS J0717 at a glance
- Code
- J0717
- Code type
- CPT/HCPCS
- Short descriptor
- Certolizumab pegol inj 1mg
- Category
- ASC Ancillary
- ASC eligibility
- ASC-eligible (ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
- Medicare ASC rate
- $3.79 national · 2026Q2
What is HCPCS code J0717?
HCPCS J0717 is a CPT/HCPCS procedure code. Its official short descriptor is "Certolizumab pegol inj 1mg". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS J0717 eligible in an ambulatory surgery center (ASC)?
HCPCS J0717 is an ancillary service that can be provided in the ASC setting when it supports a surgical procedure.
Where is HCPCS J0717 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is the Medicare ASC payment rate for HCPCS J0717?
The national Medicare ASC payment rate for HCPCS J0717 is $3.79 (CMS ASC Payment System, 2026Q2). This is the national, unadjusted amount published by CMS; the amount an individual ambulatory surgery center is paid is adjusted for local wage index and may differ. It reflects Medicare's facility payment only and does not include the surgeon's professional fee.
Reference information about ASC eligibility and typical procedure setting. Codes, descriptors, and ASC-eligibility status change over time. This is a coding reference, not billing, coding, or legal advice. Always verify against current guidance and individual payer policy before scheduling or billing. CPT is a registered trademark of the American Medical Association.